* Pharvaris NV PHVS.OQ reported a quarterly adjusted loss
of 25
cents per share for the quarter ended in September. The mean
expectation of five analysts for the quarter was for a loss
of 63 cents per share.
* Reported revenue was zero; analysts expected zero.
* Pharvaris NV's reported EPS for the quarter was a loss
of 25
cents.
* The mean earnings estimate of analysts had fallen by
about 9.8%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Pharvaris NV shares had fallen by 67.3% this quarter and
lost 82.6% so far this year.
* The company reported a quarterly loss of €8.49 million.
* Wall Street's median 12-month price target for Pharvaris
NV is
$18.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
This summary was machine generated from Refinitiv data December
8 at 12:35 p.m. All figures in euros unless otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.63 -0.25 Beat
Jun. 30 2022 -0.56 -0.38 Beat
Mar. 31 2022 -0.49 -0.48 Beat
Dec. 31 2021 -0.71 -0.09 Beat